TABLE OF CONTENTS
Volume 16, Issue 9 (September 2003)
Original Contributions
Expression of the nuclear factor-
B and proto-oncogenes c-Fos and c-Jun are induced by low extracellular mg2+ in aortic and cerebral vascular smooth muscle cells: possible links to hypertension, atherogenesis, and stroke
Burton M. Altura, Adele B. Kostellow, Aimin Zhang, Wenyan Li, Gene A. Morrill, Raj K. Gupta and Bella T. Altura
Am J Hypertens 16: 701-707; doi:10.1016/S0895-7061(03)00987-7
Eicosapentaenoic acid inhibits Ca2+ mobilization and PKC activityin vascular smooth muscle cells
Michael D. Nyby, Mark T. Hori, Bernard Ormsby, Ara Gabrielian and Michael L. Tuck
Am J Hypertens 16: 708-714; doi:10.1016/S0895-7061(03)00980-4
Treatment with amlodipine andatorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients
Eyal Leibovitz, Maya Beniashvili, Reuven Zimlichman, Angela Freiman, Marina Shargorodsky and Dov Gavish
Am J Hypertens 16: 715-718; doi:10.1016/S0895-7061(03)00949-X
Interactions of L-arginine, isosorbide mononitrate, and angiotensin II inhibitors on arterial pulse wave
Gordon S. Stokes, Edward S. Barin, Kerry L. Gilfillan and Wayne H. Kaesemeyer
Am J Hypertens 16: 719-724; doi:10.1016/S0895-7061(03)00979-8
Efficacy of screening for primary aldosteronism by adrenocortical scintigraphy without discontinuing antihypertensive medication
Hajime Nakahama, Kazuki Fukuchi, Fumiki Yoshihara, Satoko Nakamura, Takashi Inenaga, Shin Takiuchi, Kei Kamide, Takeshi Horio and Yuhei Kawano
Am J Hypertens 16: 725-728; doi:10.1016/S0895-7061(03)00948-8
No evidence of a relation between 11
-hydroxysteroid dehydrogenasetype 2 activity and salt sensitivity
Olle Melander, Erik Frandsen, Leif Groop and U. Lennart Hulthén
Am J Hypertens 16: 729-733; doi:10.1016/S0895-7061(03)00981-6
Effect of cilazapril with orwithout low dose thiazide on LDLperoxidationin hypertensive patients
Osamah Hussein, Arman Radan and Viskoper Reuven
Am J Hypertens 16: 734-738; doi:10.1016/S0895-7061(03)00977-4
Comparative efficacy and safety ofnisoldipine extended-release (ER) andamlodipine (CESNA-III study) in African American patients with hypertension
William B. White, Elijah Saunders, Robert J. Noveck and Keith Ferdinand
Am J Hypertens 16: 739-745; doi:10.1016/S0895-7061(03)00946-4
Cerebral autoregulation indicesare unimpaired by hypertensionin middle aged and older people
Penny Eames, Penelope J Eames, Melanie J Blake, Ronney B Panerai and John F Potter
Am J Hypertens 16: 746-753; doi:10.1016/S0895-7061(03)00947-6
Increased levels of insulin-like growth factor binding protein-3 in hypertensive patientswith carotid atherosclerosis
Takuya Watanabe, Masashi Itokawa, Yukiko Nakagawa, Takashi Iguchi and Takashi Katagiri
Am J Hypertens 16: 754-760; doi:10.1016/S0895-7061(03)00985-3
Peroxynitrite versus nitric oxide in early diabetes
Robert D. Hoeldtke, Kimberly D. Bryner, Daniel R. McNeill, Gerald R. Hobbs and Chris Baylis
Am J Hypertens 16: 761-766; doi:10.1016/S0895-7061(03)00976-2
Plasma homocysteine concentration and blood pressure in young adult African Americans
Rajani Dinavahi, Nicole Cossrow, Harvey Kushner and Bonita Falkner
Am J Hypertens 16: 767-770; doi:10.1016/S0895-7061(03)00986-5
Renal interstitial Ca2+ during sodium loading of normotensive and Dahl-salt hypertensive rats
Cassandra E. Palmer, M. Audrey Rudd and Richard D. Bukoski
Am J Hypertens 16: 771-776; doi:10.1016/S0895-7061(03)00914-2
Brief communication
Chlamydia pneumoniae and Epstein-Barr antibodies are not associated with carotid thickness: the effect of hypertension
Vassiliki C. Pitiriga, Vasilios T. Kotsis, Vassiliki Gennimata, Maria-Eleni K. Alexandrou, Christos M. Papamichail, Dimitrios N. Mitsibounas, Vassiliky D. Petrocheilou-Paschou and Nikos A. Zakopoulos
Am J Hypertens 16: 777-780; doi:10.1016/S0895-7061(03)00945-2
Review
Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy
Atsuhisa Sato and Takao Saruta
Am J Hypertens 16: 781-788; doi:10.1016/S0895-7061(03)00913-0
Editorial
NHLBI's conflict of interest: why we need the data quality act
David A. McCarron
Am J Hypertens 16: 789-791; doi:10.1016/S0895-7061(03)00964-6
